CMS 134 - Diabetes: Medical Attention for Nephropathy

Share

Covered by this topic

Overview

CMS134v8 (2020)
CMS134v9 (2021)
CMS134v10 (2022)

Identifiers

CMS eCQM IDNQF eCQM IDNQFMIPS Quality ID
CMS134v10–0062119
*MIE only supports data collection and reporting using eCQM specifications

Definitions

DescriptionThe percentage of patients 18-75 years of age with diabetes who had a nephropathy screening test or evidence of nephropathy during the measurement period
Initial Patient PopulationPatients 18-75 years of age with diabetes with a visit during the measurement period
DenominatorEquals Initial Population
Denominator Exclusions

  • Exclude patients who are in hospice care for any part of the measurement period.

  • Exclude patients 66 and older who are living long term in an institution for more than 90 consecutive days during the measurement period.

  • Exclude patients 66 and older with an indication of frailty for any part of the measurement period who meet any of the following criteria:

    • Advanced illness with two outpatient encounters during the measurement period or the year prior

    • Advanced illness with one inpatient encounter during the measurement period or the year prior

    • Taking dementia medications during the measurement period or the year prior

  • Exclude patients receiving palliative care during the measurement period.

NumeratorPatients with a screening for nephropathy or evidence of nephropathy during the measurement period
Numerator Exclusions–
Denominator Exceptions–

Additional Information

Measure TypeProcess measure
Measure ScoringProportion measure
GranularityPatient
Improvement NotationHigher score indicates better quality
DomainEffective Clinical Care

Clinical Instructions

New UI Visit Encounter (valid RC202109+)

Original Visit Encounter

Evidence

Initial Patient Population

NameValue Set
Diagnosis: Diabetes2.16.840.1.113883.3.464.1003.103.12.1001
Encounter, Performed: Annual Wellness Visit2.16.840.1.113883.3.526.3.1240
Encounter, Performed: ESRD Monthly Outpatient Services2.16.840.1.113883.3.464.1003.109.12.1014
Encounter, Performed: Home Healthcare Services2.16.840.1.113883.3.464.1003.101.12.1016
Encounter, Performed: Observation2.16.840.1.113883.3.464.1003.101.12.1086
Encounter, Performed: Office Visit2.16.840.1.113883.3.464.1003.101.12.1001
Encounter, Performed: Preventive Care Services - Established Office Visit, 18 and Up2.16.840.1.113883.3.464.1003.101.12.1025
Encounter, Performed: Preventive Care Services-Initial Office Visit, 18 and Up2.16.840.1.113883.3.464.1003.101.12.1023
Encounter, Performed: Telephone Visits2.16.840.1.113883.3.464.1003.101.12.1080

Denominator Exclusions

NameValue Set
Assessment, Performed: Functional Assessment of Chronic Illness Therapy - Palliative Care Questionnaire (FACIT-Pal)LOINC Code 71007-9
Device, Applied: Frailty Device2.16.840.1.113883.3.464.1003.118.12.1300
Device, Order: Frailty Device2.16.840.1.113883.3.464.1003.118.12.1300
Diagnosis: Frailty Diagnosis2.16.840.1.113883.3.464.1003.113.12.1074
Encounter, Performed: Acute Inpatient2.16.840.1.113883.3.464.1003.101.12.1083
Encounter, Performed: Care Services in Long-Term Residential Facility2.16.840.1.113883.3.464.1003.101.12.1014
Encounter, Performed: Emergency Department Visit2.16.840.1.113883.3.464.1003.101.12.1010
Encounter, Performed: Encounter Inpatient2.16.840.1.113883.3.666.5.307
Encounter, Performed: Frailty Encounter2.16.840.1.113883.3.464.1003.101.12.1088
Encounter, Performed: Nonacute Inpatient2.16.840.1.113883.3.464.1003.101.12.1084
Encounter, Performed: Nursing Facility Visit2.16.840.1.113883.3.464.1003.101.12.1012
Encounter, Performed: Observation2.16.840.1.113883.3.464.1003.101.12.1086
Encounter, Performed: Outpatient2.16.840.1.113883.3.464.1003.101.12.1087
Encounter, Performed: Palliative Care Encounter2.16.840.1.113883.3.464.1003.101.12.1090
Intervention, Order: Hospice care ambulatory2.16.840.1.113762.1.4.1108.15
Intervention, Performed: Hospice care ambulatory2.16.840.1.113762.1.4.1108.15)
Intervention, Performed: Palliative Care Intervention2.16.840.1.113883.3.464.1003.198.12.1135
Medication, Active: Dementia Medications2.16.840.1.113883.3.464.1003.196.12.1510
Symptom: Frailty Symptom2.16.840.1.113883.3.464.1003.113.12.1075

Numerator

NameValue Set
Diagnosis: Diabetic Nephropathy2.16.840.1.113883.3.464.1003.109.12.1004
Diagnosis: Glomerulonephritis and Nephrotic Syndrome2.16.840.1.113883.3.464.1003.109.12.1018
Diagnosis: Hypertensive Chronic Kidney Disease2.16.840.1.113883.3.464.1003.109.12.1017
Diagnosis: Kidney Failure2.16.840.1.113883.3.464.1003.109.12.1028
Diagnosis: Proteinuria2.16.840.1.113883.3.526.3.1003
Intervention, Performed: Dialysis Education2.16.840.1.113883.3.464.1003.109.12.1016
Intervention, Performed: Other Services Related to Dialysis2.16.840.1.113883.3.464.1003.109.12.1015
Laboratory Test, Performed: Urine Protein Tests2.16.840.1.113883.3.464.1003.109.12.1024
Medication, Active: ACE Inhibitor or ARB or ARNI2.16.840.1.113883.3.526.3.1139
Procedure, Performed: Dialysis Services2.16.840.1.113883.3.464.1003.109.12.1013
Procedure, Performed: Kidney Transplant2.16.840.1.113883.3.464.1003.109.12.1012

Source(s)

eCQI CMS134

Did this doc help you?

Enterprise Health Documentation

Page Created:
Last Updated:
Last Build: Sun, 13 Nov 2022 01:02:21 UTC
WikiGDrive Version: 8799ccfd58b47ed721e42eeadb589071776ed64f